Skip to main content

Table 2 Comparison between the different studied groups according to ammonia and BDNF

From: Diagnostic role of serum brain-derived neurotrophic factor in HCV cirrhotic patients with minimal hepatic encephalopathy with and without schistosomiasis

 

Group 1 (n = 20)

Group 2 (n = 20)

Group 3 (n = 20)

Group 4 (n = 20)

Test of sig

p

Ammonia (mg/dl)

 Min. – Max

87.0–153.0

52.0–114.0

60.0–121.0

28.0–67.0

F = 53.036*

 < 0.001*

 Median (IQR)

114.35 ± 17.48

76.85 ± 18.96

84.70 ± 17.13

49.90 ± 10.09

p0

 < 0.001*

 < 0.001*

 < 0.001*

   

Sig. bet. grps

p1 < 0.001*, p2 < 0.001*, p3 = 0.428

   

BDNF (pg/ml)

 Min. – Max

36.34–252.65

59.09–475.06

101.46–317.47

211.80–408.31

H = 34.254*

 < 0.001*

 Median (IQR)

126.69 (91.63–202.92)

121.87 (102.33–156.74)

175.65 (121.42– 237.38)

261.72 (247.46–282.67)

p0

 < 0.001*

 < 0.001*

 < 0.001*

   

Sig. bet. grps

p1 = 0.001*, p2 = 0.035*, p3 = 0.698

   
  1. χ2 chi-square test, SD Standard deviation, p3, p value for comparing between group 2 and group 3; p2, p value for comparing between group 1 and group 3; p1, p value for comparing between group 1 and group 2; p0, p value for comparing between group 4 and each other group; p, p value for comparing between the different studied groups; IQR, interquartile range; H, Kruskal–Wallis test, pairwise comparison bet. each 2 groups was done using post hoc test (Dunn’s for multiple comparisons test); FE Fisher exact, F one-way ANOVA test, pairwise comparison bet. each 2 groups was done using post hoc test (Tukey); BDNF, brain-derived neurotrophic factor
  2. *Statistically significant at p ≤ 0.05